Paper17544971
Role of radiologic modalities in the management of non-alcoholic steatohepatitis.
Charatcharoenwitthaya P and 1 other. Clin Liver Dis, 2007. Cited by 141 papers, by iCite.
Cite this record
ConductScience Library. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Papers, record 17544971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17544971
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fatty Liver | Major topic |
| Hepatitis | Major topic |
| Humans | |
| Magnetic Resonance Imaging | |
| Magnetic Resonance Spectroscopy | |
| Tomography, X-Ray Computed | |
| Ultrasonography |
Source PubMed
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41828627 | The Usefulness of Metformin and Ganwei for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized, Placebo-Controlled Trial. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828627 | PubMed |
| 40879966 | Non-alcoholic steatohepatitis incidence in patients with psoriasis vulgaris. | Wien Med Wochenschr | 2025 | https://conductscience.org/library/papers/40879966 | PubMed |
| 40042310 | MR and Ultrasound for Liver Fat Assessment in Children: Techniques and Supporting Evidence. | J Magn Reson Imaging | 2025 | https://conductscience.org/library/papers/40042310 | PubMed |
| 39123437 | Prospective Study of Non-Contrast, Abbreviated MRI for Hepatocellular Carcinoma Surveillance in Patients with Suboptimal Hepatic Visualisation on Ultrasound. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39123437 | PubMed |
| 38188964 | Multifocal fatty liver nodules mimicking a metastatic disease: A case report. | Radiol Case Rep | 2024 | https://conductscience.org/library/papers/38188964 | PubMed |
| 37929252 | Variation in hepatic segmental portal venous pulsed wave Doppler flow distribution in patients with NAFLD: A pilot study. | Ultrasound | 2023 | https://conductscience.org/library/papers/37929252 | PubMed |
| 37408709 | The Role of ElastPQ in Assessing Liver Stiffness for Non-Alcoholic Fatty Liver Disease in Patients Treated with Atypical Antipsychotic Drugs. | Neuropsychiatr Dis Treat | 2023 | https://conductscience.org/library/papers/37408709 | PubMed |
| 37389233 | Prospective study comparing hepatic steatosis assessment by magnetic resonance imaging and four ultrasound methods in 105 successive patients. | World J Gastroenterol | 2023 | https://conductscience.org/library/papers/37389233 | PubMed |
| 37303246 | The Abdominal Ultrasonography Results of Cappadocia Cohort Study of Turkey Reveals High Prevalence of Fatty Liver. | Turk J Gastroenterol | 2023 | https://conductscience.org/library/papers/37303246 | PubMed |
| 36938188 | Relationship Between Vitamin D Deficiency and Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study From a Tertiary Care Center in Northern India. | Cureus | 2023 | https://conductscience.org/library/papers/36938188 | PubMed |
| 36503204 | Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future. | Clin Mol Hepatol | 2023 | https://conductscience.org/library/papers/36503204 | PubMed |
| 36330440 | Fasting glucose mediates the influence of genetic variants of SOD2 gene on lean non-alcoholic fatty liver disease. | Front Genet | 2022 | https://conductscience.org/library/papers/36330440 | PubMed |
| 36144285 | Association of Metabolic Signatures with Nonalcoholic Fatty Liver Disease in Pediatric Population. | Metabolites | 2022 | https://conductscience.org/library/papers/36144285 | PubMed |
| 35661987 | Non-invasive diagnosis and staging of non-alcoholic fatty liver disease. | Hormones (Athens) | 2022 | https://conductscience.org/library/papers/35661987 | PubMed |
| 35388643 | Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH. | Endocrinol Diabetes Metab | 2022 | https://conductscience.org/library/papers/35388643 | PubMed |
| 35011784 | Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects. | J Clin Med | 2021 | https://conductscience.org/library/papers/35011784 | PubMed |
| 34191823 | Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease. | PLoS One | 2021 | https://conductscience.org/library/papers/34191823 | PubMed |
| 33672827 | Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33672827 | PubMed |
| 33093619 | Association of gamma-glutamyl transferase with subclinical coronary atherosclerosis and cardiac outcomes in non-alcoholics. | Sci Rep | 2020 | https://conductscience.org/library/papers/33093619 | PubMed |
| 30190781 | Current status of imaging in nonalcoholic fatty liver disease. | World J Hepatol | 2018 | https://conductscience.org/library/papers/30190781 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17544971
GET https://conductscience.org/api/papers/v1/17544971/cited_by?page=2